| Feb 15, 2019 |
Feb 19, 2019 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
52.5
|
-775
|
-0.26%
|
✓
|
$30.7K |
| Feb 11, 2019 |
Feb 11, 2019 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
35.0
|
-13,975
|
-4.56%
|
✓
|
$538.7K |
| Feb 6, 2019 |
Feb 8, 2019 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
67.5
|
+1,113
|
0.36%
|
✓
|
$536.1K |
| Nov 15, 2018 |
Nov 15, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
52.5
|
-775
|
-0.25%
|
✓
|
$26.2K |
| Sep 26, 2018 |
Sep 27, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
35.0
|
-13,500
|
-4.22%
|
✓
|
$581.6K |
| Sep 24, 2018 |
Sep 25, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
23.8
|
-31,500
|
-8.97%
|
✓
|
$1.3M |
| Aug 15, 2018 |
Aug 16, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
53.8
|
-775
|
-0.22%
|
✓
|
$29.1K |
| May 15, 2018 |
May 16, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
27.5
|
-25,775
|
-6.82%
|
✓
|
$1.2M |
| Mar 26, 2018 |
Mar 27, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
35.0
|
-18,327
|
-4.94%
|
✓
|
$729.3K |
| Feb 9, 2018 |
Feb 12, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
22.5
|
-4,925
|
-1.31%
|
✗
|
$205.4K |
| Feb 6, 2018 |
Feb 8, 2018 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
87.5
|
+13,074
|
3.61%
|
✗
|
$158.5K |
| Nov 15, 2017 |
Nov 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
52.5
|
-1,604
|
-0.44%
|
✓
|
$21.4K |
| Oct 16, 2017 |
Oct 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.62%
|
✓
|
$86.1K |
| Sep 15, 2017 |
Sep 18, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.60%
|
✓
|
$91.8K |
| Aug 15, 2017 |
Aug 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-7,604
|
-1.99%
|
✓
|
$112.2K |
| Jul 17, 2017 |
Jul 18, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.55%
|
✓
|
$89.5K |
| Jun 15, 2017 |
Jun 16, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.52%
|
✓
|
$75.9K |
| May 15, 2017 |
May 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-7,604
|
-1.89%
|
✓
|
$114K |
| Apr 17, 2017 |
Apr 19, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.47%
|
✓
|
$103.7K |
| Mar 15, 2017 |
Mar 17, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.45%
|
✓
|
$117.6K |
| Feb 15, 2017 |
Feb 16, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-7,604
|
-1.81%
|
✓
|
$117.8K |
| Feb 9, 2017 |
Feb 10, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
37.5
|
-13,975
|
-3.22%
|
✓
|
$216.1K |
| Jan 17, 2017 |
Jan 18, 2017 |
Atara Biotherapeutics, Inc.
|
EVP, R&D & Chief Scientific Of |
Sell |
45.0
|
-6,000
|
-1.54%
|
✓
|
$85.6K |
| Dec 15, 2016 |
Dec 15, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
45.0
|
-6,000
|
-1.51%
|
✓
|
$92.4K |
| Nov 21, 2016 |
Nov 22, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
45.0
|
-7,068
|
-1.75%
|
✓
|
$126.2K |
| Nov 15, 2016 |
Nov 17, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
52.5
|
-1,604
|
-0.40%
|
✓
|
$32K |
| Aug 15, 2016 |
Aug 17, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
52.5
|
-1,346
|
-0.43%
|
✓
|
$30K |
| May 16, 2016 |
May 18, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
51.3
|
-1,605
|
-0.51%
|
✓
|
$25K |
| Feb 16, 2016 |
Feb 18, 2016 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
48.8
|
-3,208
|
-1.01%
|
✓
|
$49.5K |
| Aug 31, 2015 |
Sep 1, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
45.0
|
-5,000
|
-1.88%
|
✓
|
$210K |
| Aug 17, 2015 |
Aug 19, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
47.5
|
-1,604
|
-0.60%
|
✓
|
$73.6K |
| Jul 31, 2015 |
Aug 3, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
47.5
|
-2,500
|
-0.93%
|
✓
|
$138.6K |
| Jul 15, 2015 |
Jul 15, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
47.5
|
-2,500
|
-0.92%
|
✓
|
$157.4K |
| Jul 1, 2015 |
Jul 2, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
47.5
|
-2,500
|
-0.91%
|
✓
|
$129.2K |
| Jun 15, 2015 |
Jun 16, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
38.8
|
-7,500
|
-2.66%
|
✓
|
$348.1K |
| Jun 1, 2015 |
Jun 1, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
47.5
|
-2,500
|
-0.88%
|
✓
|
$103.7K |
| May 15, 2015 |
May 19, 2015 |
Atara Biotherapeutics, Inc.
|
Chief Medical Officer |
Sell |
32.5
|
-1,887
|
-0.66%
|
✗
|
$70.4K |